arginine and Fatty Liver, Nonalcoholic

arginine has been researched along with Fatty Liver, Nonalcoholic in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (64.71)24.3611
2020's6 (35.29)2.80

Authors

AuthorsStudies
Baumann, A; Bergheim, I; Brandt, A; Jung, F; Nier, A; Rajcic, D; Sánchez, V; Staltner, R; Staufer, K; Trauner, M1
Bonnitcha, P; Fitzpatrick, M; Ireland, A; Koay, YC; Nguyen, VL; O'Sullivan, J; Sullivan, D1
Hu, Q; Hua, C; Huo, G; Jiang, H; Li, S; Wu, Y; Zhou, F; Zhu, H1
Gopko, OF; Lymanets, TV; Maslova, GS; Skrypnyk, IМ; Skrypnyk, RІ1
Bruno, RS; Cichon, MJ; Kopec, RE; Li, J; Sasaki, GY1
Baum, SJ; Chakravarthy, MV; Chera, H; Gunn, NT; Harrison, SA; Kohli, A; Koziel, MJ; Patil, R; Younes, ZH; Zhao, J1
Bergheim, I; De Bandt, JP; Degen, C; Engstler, AJ; Hasan Alkhatib, D; Jin, CJ; Nier, A; Sellmann, C1
Anavi, S; Hahn-Obercyger, M; Tirosh, O; Voloshin, I1
Bergheim, I; Beutheu, S; Cynober, L; De-Bandt, JP; Jegatheesan, P; Kapel, N; Nubret, E; Sarfati, G; Ventura, G; Waligora-Dupriet, AJ1
Dhakal, IB; Hakkak, R; Korourian, S; Zeng, H1
Alkim, C; Alkim, H; Bayram, M; Boga, S; Ergun, M; Koksal, AR; Neijmann, ST; Ozgon, G; Ozguven, MB1
Bergheim, I; Beutheu, S; De Bandt, JP; Jegatheesan, P; Nubret, E; Sarfati, G; Ventura, G1
Abu-Serie, MM; El-Gamal, BA; El-Kersh, MA; El-Saadani, MA1
Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S1
Colak, Y; Coskunpinar, E; Doganay, L; Kahraman, OT; Mesci, B; Ozturk, O; Senates, E; Tuncer, I; Ulasoglu, C; Yesil, A; Yilmaz, Y1
Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Karslioglu, Y; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S1
Chayama, K; Fukami, K; Hyogo, H; Ishitobi, T; Kimura, Y; Maeda, S; Nakahara, T; Okuda, S; Ueda, S; Yamagishi, S1

Trials

1 trial(s) available for arginine and Fatty Liver, Nonalcoholic

ArticleYear
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
    The American journal of gastroenterology, 2021, 12-01, Volume: 116, Issue:12

    Topics: Acetylcysteine; Administration, Oral; Arginine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Female; Glutamine; Humans; Isoleucine; Leucine; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Single-Blind Method; Treatment Outcome; Valine

2021

Other Studies

16 other study(ies) available for arginine and Fatty Liver, Nonalcoholic

ArticleYear
Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:4

    Topics: Animals; Arginine; Female; Homeostasis; Humans; Liver; Mice; Mice, Inbred C57BL; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Toll-Like Receptor 4

2022
Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma.
    Pathology, 2022, Volume: 54, Issue:5

    Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Tandem Mass Spectrometry

2022
    Nutrients, 2022, Oct-01, Volume: 14, Issue:19

    Topics: Agaricales; Animals; Antioxidants; Arginine; Biomarkers; Diet, High-Fat; Fucose; Galactose; Glucose; Glycerides; Glycerol; Isoleucine; Leucine; Lipid Metabolism; Lipid Metabolism Disorders; Liver; Mannose; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phospholipids; Polysaccharides; Proline; Spectroscopy, Fourier Transform Infrared; Steroids; Valine; Xylose

2022
Arginine/citrulline cycle changes in diet-induced rat model of non-alcoholic fatty liver disease.
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2020, Volume: 73, Issue:6

    Topics: Animals; Arginine; Citrulline; Diet; Female; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley

2020
Catechin-Rich Green Tea Extract and the Loss-of-TLR4 Signaling Differentially Alter the Hepatic Metabolome in Mice with Nonalcoholic Steatohepatitis.
    Molecular nutrition & food research, 2021, Volume: 65, Issue:2

    Topics: Acetyl Coenzyme A; Animals; Arginine; Bile Acids and Salts; Catechin; Dietary Supplements; Genotype; Glutathione; Insulin Resistance; Liver; Male; Metabolome; Mice, Inbred C3H; Mice, Mutant Strains; Non-alcoholic Fatty Liver Disease; Spermidine; Tea; Toll-Like Receptor 4

2021
Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
    Amino acids, 2017, Volume: 49, Issue:7

    Topics: Administration, Oral; Animals; Arginine; Blood Glucose; Dietary Supplements; Female; Intestine, Small; Liver; Mice; Non-alcoholic Fatty Liver Disease; Tight Junctions; Toll-Like Receptor 4

2017
L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease.
    Lipids in health and disease, 2014, Apr-22, Volume: 13

    Topics: Animals; Arginine; Body Weight; Chenodeoxycholic Acid; Eating; Esters; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease

2014
Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.
    Clinical nutrition (Edinburgh, Scotland), 2016, Volume: 35, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Arginine; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholesterol; Citrulline; Dietary Supplements; Fructose; Glutamine; Hypertriglyceridemia; Insulin; Insulin Resistance; Intestinal Absorption; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; RNA, Messenger; Toll-Like Receptor 4; Triglycerides; Tumor Necrosis Factor-alpha

2016
Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content.
    Journal of medicinal food, 2015, Volume: 18, Issue:11

    Topics: Alanine Transaminase; Animals; Arginine; Aspartate Aminotransferases; Caseins; Diet; Dietary Supplements; Interleukin-6; Isoflavones; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Rats, Zucker; Soybean Proteins; Tumor Necrosis Factor-alpha

2015
Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2015, Volume: 63, Issue:7

    Topics: Adult; Arginine; C-Reactive Protein; Case-Control Studies; Female; Humans; Inflammation; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease

2015
Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats.
    The Journal of nutrition, 2015, Volume: 145, Issue:10

    Topics: Algorithms; Amino Acids; Animals; Arginine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biomarkers; Citrulline; Dietary Supplements; Fatty Acid Synthase, Type I; Fructose; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Humans; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Ornithine; PPAR alpha; Random Allocation; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 1

2015
Investigation into the antioxidant role of arginine in the treatment and the protection for intralipid-induced non-alcoholic steatohepatitis.
    Lipids in health and disease, 2015, Oct-14, Volume: 14

    Topics: Animals; Antioxidants; Arginine; Cytochrome P-450 CYP2E1; Emulsions; Glutathione; Glutathione Peroxidase; Injections, Intraperitoneal; Injections, Intravenous; Lipid Peroxidation; Liver; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Phospholipids; Protective Agents; Rats; Rats, Sprague-Dawley; Soybean Oil; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha

2015
Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
    Diabetes research and clinical practice, 2012, Volume: 96, Issue:1

    Topics: Adult; Arginine; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Fatty Liver; Humans; Male; Non-alcoholic Fatty Liver Disease; Young Adult

2012
Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
    Endocrine, 2013, Volume: 43, Issue:1

    Topics: Adult; Arginine; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Early Diagnosis; Endothelium, Vascular; Fatty Liver; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Practice Guidelines as Topic; Predictive Value of Tests; Severity of Illness Index; Vascular Diseases; Vasodilation

2013
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Clinical endocrinology, 2013, Volume: 78, Issue:5

    Topics: Adiponectin; Adult; alpha-2-HS-Glycoprotein; Arginine; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Fatty Liver; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Young Adult

2013
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients.
    Clinical and experimental medicine, 2014, Volume: 14, Issue:1

    Topics: Adult; Aged; Arginine; Fatty Liver; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Procollagen; Serum

2014